A scientific review titled “Dragon Fruit Phytochemistry and Pharmacological Evidence Review” has been authored by researchers affiliated with institutions including Shri Ratanlal Kanwarlal Patni Girls’ College, Kishangarh, Ajmer, Rajasthan. The paper examines the phytochemical composition and pharmacological evidence of dragon fruit.
Job Overview
Selenicereus spp., commonly known as dragon fruit or pitaya, has drawn significant research interest beyond its nutritional profile. The pulp, peel, and seeds contain phenolic acids, flavonoids, betalains, anthocyanins, polysaccharides, and terpenoids. Each compound class has shown measurable biological activity in preclinical models, with reported antioxidant, anti-inflammatory, antimicrobial, antidiabetic, anticancer, hepatoprotective, neuroprotective, and prebiotic effects. This review draws on 50 peer-reviewed studies to assess what the phytochemical evidence actually shows, where it holds up, and where it falls short.
Conclusion
The phytochemical profile of dragon fruit is well-documented, and its antioxidant, anti-inflammatory, antimicrobial, and metabolic effects in preclinical models are reproducible. Anticancer and neuroprotective findings are mechanistically interesting but confined to cell studies. Human clinical evidence is absent across all of these domains. Meaningful therapeutic application requires standardisation of raw material quality and further human trials.
